Clinical Trial: "Less-is-more in Barrett-surveillance": Care Evaluation of Barrett's Patients with Low-Risk in Whom Endoscopic Surveillance is Stopped. the BLISS Project.

U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06803147) titled '"Less-is-more in Barrett-surveillance": Care Evaluation of Barrett's Patients with Low-Risk in Whom Endoscopic Surveillance is Stopped. the BLISS Project.' on Jan. 26.

Brief Summary: Rationale:

Until recently, the conventional strategy outlined by both national and international guidelines for managing non-dysplastic (ND) Barrett's esophagus (BE), involved endoscopic surveillance at 3 to 5 year intervals, aiming to reduce mortality from esophageal adenocarcinoma (EAC) through early detection and treatment. However, scientific evidence that supports the benefits in EAC-specific and/or overall survival, or that shows cost-effectivenes...